SRNE

Sorrento Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
-1.36 -17.13% 6.58 6.29 7.93 7.9022 7.94 19:59:52
more quote information »

Recent News

Date Time Source Heading
7/01/202016:39EDGARCurrent Report Filing (8-k)
7/01/202012:06GLOBESorrento Announces Selection of T-VIVA-19™ as Targeted..
6/30/202016:37EDGARCurrent Report Filing (8-k)
6/15/202018:11EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:11EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:11EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:10EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:10EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:09EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:09EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:08EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202018:08EDGARStatement of Changes in Beneficial Ownership (4)
6/12/202016:12EDGARCurrent Report Filing (8-k)
6/12/202015:21GLOBESorrento Announces Full Repayment of Outstanding Term Loans
6/10/202021:57GLOBESorrento Announces It Has Submitted an Emergency Use..
6/05/202009:32EDGARCurrent Report Filing (8-k)
6/05/202009:30PRNUSSorrento COVIDTRAP™(STI-4398) Demonstrates in Preclinical..
5/26/202009:00GLOBESorrento Receives FDA IND Clearance to Initiate a Phase I..
5/21/202007:01EDGARCurrent Report Filing (8-k)
5/21/202007:00GLOBESorrento Enters Into Binding Term Sheet to Acquire Exclusive..
5/15/202013:53EDGARCurrent Report Filing (8-k)
5/15/202011:00PRNUSSTI-1499, A Potent Anti-SARS-CoV-2 Antibody, Demonstrates..
5/11/202016:03EDGARQuarterly Report (10-q)
5/08/202009:20PRNUSSorrento And Mount Sinai Health System To Jointly Develop..
4/27/202016:39EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/27/202016:39EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
4/27/202016:38EDGARCurrent Report Filing (8-k)
4/09/202017:17EDGARAmended Statement of Ownership (sc 13g/a)
4/02/202012:33GLOBESORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS..
3/31/202014:01GLOBESORRENTO AND THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT..
3/31/202006:11EDGARCurrent Report Filing (8-k)
3/25/202010:00GLOBESorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine..
3/24/202017:02EDGARUnknown (sec Staff)
3/24/202016:12EDGARUnknown (sec Staff)
3/24/202009:32GLOBESORRENTO COLLABORATES WITH MABPHARM ON DEVELOPMENT AND..
3/23/202009:00GLOBESORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL..
3/23/202006:01EDGARNotice of Effectiveness (effect)
3/20/202007:01EDGARCurrent Report Filing (8-k)
3/20/202007:00GLOBESORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR..
3/13/202006:01EDGARSecurities Registration Statement (simplified Form) (s-3)
3/06/202016:42EDGARCurrent Report Filing (8-k)
3/05/202013:59EDGARStatement of Changes in Beneficial Ownership (4)
3/03/202006:09EDGARAnnual Report (10-k)
2/27/202015:30GLOBESorrento Therapeutics Presents Interim Positive Results of..
2/27/202006:19EDGARCurrent Report Filing (8-k)
2/27/202006:00GLOBESorrento to Provide Corporate Update, Including DAR-T Cell..
2/21/202010:48EDGARUnknown (sec Staff)
2/21/202010:47EDGARUnknown (sec Staff)
2/21/202009:15GLOBESorrento Therapeutics CEO Dr. Ji to Present at LEERINK..
2/14/202006:14EDGARAmended Statement of Ownership (sc 13g/a)
See more news about this stock »
Your Recent History
NASDAQ
SRNE
Sorrento T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200716 03:04:33